XW Laboratories: XW Labs' XWL─008 receives US FDA orphan drug status to treat patients with narcolepsy

XW Laboratories Inc. (XW Labs), a clinical─stage bio pharmaceutical company pioneering the discovery of novel small molecule therapeutics for the treatment of neurological disorders, announced that the US Food and Drug Administration (FDA)